MedTrace Logo

Utilization of the TAD Device for Dispensing Pain Medications in Hospice Patients

NCT03940534 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2019-05-08

No results posted yet for this study

Summary

A novel device, TAD, has been developed to aid adherence to prescribed regimens and may have a roll in hospice pain management. This study aims to assess medication adherence relating to missed doses or improperly timed doses with and without the aid of a mobile device as a primary endpoint. Secondary endpoints will be patient, nursing, and provider satisfaction.

Conditions

  • Medication Adherence
  • Satisfaction, Personal

Interventions

DEVICE

TAD

TAD is a device used to aid medication adherence.

Sponsors & Collaborators

  • Intent Solutions, Inc.

    lead INDUSTRY

Principal Investigators

  • Christopher E Richter, PharmD · Clinical Pharmacist

  • Ellen Talos, MD · Medical Director

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-09
Primary Completion
2019-02-26
Completion
2019-02-26
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03940534 on ClinicalTrials.gov